Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

A 21-year-old had a rare developmental anomaly with a misplaced sebaceous gland in a hair follicle.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Understanding how acne develops in different diseases could lead to new treatments.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Most skin diseases in Hajjah, Yemen, were dermatitis, infections, and acne, influenced by local socioeconomic and environmental factors.

The case suggests a possible link between severe acne and certain bone deformities.